{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:40:05Z","timestamp":1790797205918,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000},"content-version":"am","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NIH Vaccine Trials and Evaluation Unit","award":["HHSN272200800008C"],"award-info":[{"award-number":["HHSN272200800008C"]}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["#39129"],"award-info":[{"award-number":["#39129"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1055855"],"award-info":[{"award-number":["OPP1055855"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.vaccine.2017.06.013","type":"journal-article","created":{"date-parts":[[2017,6,26]],"date-time":"2017-06-26T23:46:31Z","timestamp":1498520791000},"page":"4255-4261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["CD11a and CD49d enhance the detection of antigen-specific T cells following human vaccination"],"prefix":"10.1016","volume":"35","author":[{"given":"Allison F.","family":"Christiaansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upasna Gaur","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhea N.","family":"Coler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Marie Beckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia L.","family":"Winokur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Bridget","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.06.013_b0005","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.4049\/jimmunol.1103640","article-title":"The utility and limitations of current web-available algorithms to predict peptides recognized by CD4 T cells in response to pathogen infection","volume":"188","author":"Chaves","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.06.013_b0010","doi-asserted-by":"crossref","first-page":"11734","DOI":"10.1128\/JVI.00435-08","article-title":"Lymphocytic choriomeningitis virus infection yields overlapping CD4 and CD8 T-Cell responses","volume":"82","author":"Dow","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.06.013_b0015","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.4049\/jimmunol.179.2.1058","article-title":"Chronic lymphocytic choriomeningitis virus infection actively down-regulates CD4+ T Cell responses directed against a broad range of epitopes","volume":"179","author":"Moth\u00e9","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.06.013_b0020","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.4049\/jimmunol.161.7.3215","article-title":"Cutting edge: detection of a high frequency of virus-specific CD4 T Cells during acute infection with lymphocytic choriomeningitis virus","volume":"161","author":"Varga","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.06.013_b0025","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.4161\/hv.29375","article-title":"Evaluation of the immune response to RTS, S\/AS01 and RTS, S\/AS02 adjuvanted vaccines: randomized, double-blind study in malaria-naive adults","volume":"10","author":"Leroux-Roels","year":"2014","journal-title":"Human Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2017.06.013_b0030","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T Cell populations","volume":"28","author":"Zhu","year":"2010","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.vaccine.2017.06.013_b0035","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.4049\/jimmunol.1102104","article-title":"Quantifying antigen-specific CD4 T cells during a viral infection: CD4 T cell responses are larger than we think","volume":"187","author":"McDermott","year":"2011","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"key":"10.1016\/j.vaccine.2017.06.013_b0040","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","article-title":"Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm","volume":"76","author":"Springer","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2017.06.013_b0045","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1128\/IAI.00749-12","article-title":"CD11a regulates effector CD8 T cell differentiation and central memory development in response to infection with Listeria monocytogenes","volume":"81","author":"Bose","year":"2013","journal-title":"Infect Immun."},{"key":"10.1016\/j.vaccine.2017.06.013_b0050","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.4049\/jimmunol.173.2.1209","article-title":"Activation, differentiation, and migration of naive virus-specific CD8 T Cells during pulmonary influenza virus infection","volume":"173","author":"Lawrence","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.06.013_b0055","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2008-04-150524","article-title":"CD49d provides access to \u201cuntouched\u201d human Foxp3+ Treg free of contaminating effector cells","volume":"113","author":"Kleinewietfeld","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2017.06.013_b0060","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4049\/jimmunol.150.2.429","article-title":"Both CD45RA+ and CD45RA- subpopulations of CD8+ T cells contain cells with high levels of lymphocyte function-associated antigen-1 expression, a phenotype of primed T cells","volume":"150","author":"Okumura","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.06.013_b0065","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1038\/cti.2015.6","article-title":"From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE","volume":"4","author":"Coler","year":"2015","journal-title":"Clin Trans Immunol"},{"key":"10.1016\/j.vaccine.2017.06.013_b0070","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/eji.201444543","article-title":"Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-gamma","volume":"45","author":"Desbien","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2017.06.013_b0075","doi-asserted-by":"crossref","first-page":"e16333","DOI":"10.1371\/journal.pone.0016333","article-title":"Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant","volume":"6","author":"Coler","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2017.06.013_b0080","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1128\/IAI.00394-07","article-title":"Leish-111f, a Recombinant polyprotein vaccine that protects against visceral leishmaniasis by elicitation of CD4+ T Cells","volume":"75","author":"Coler","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.06.013_b0085","doi-asserted-by":"crossref","first-page":"7672","DOI":"10.4049\/jimmunol.0902874","article-title":"Tracking the total CD8 T Cell response to infection reveals substantial discordance in magnitude and kinetics between inbred and outbred hosts","volume":"183","author":"Rai","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.06.013_b0090","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1128\/JVI.01459-06","article-title":"Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: it is even bigger than we thought","volume":"81","author":"Masopust","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.06.013_b0095","doi-asserted-by":"crossref","first-page":"9010","DOI":"10.1128\/JVI.00329-14","article-title":"The pulmonary Localization of virus-specific T lymphocytes Is governed by the tissue tropism of infection","volume":"88","author":"Knudson","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.06.013_b0100","doi-asserted-by":"crossref","first-page":"e90720","DOI":"10.1371\/journal.pone.0090720","article-title":"Depletion of alveolar macrophages ameliorates virus-induced disease following a pulmonary coronavirus infection","volume":"9","author":"Hartwig","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2017.06.013_b0105","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/ni.2180","article-title":"Therapeutic PD-L1 and LAG-3 blockade rapidly clears established blood-stage plasmodium infection","volume":"13","author":"Butler","year":"2011","journal-title":"Nature Immunol"},{"key":"10.1016\/j.vaccine.2017.06.013_b0110","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1128\/IAI.02101-14","article-title":"Early induction of Interleukin-10 limits antigen-specific CD4 T cell expansion, function, and secondary recall responses during persistent phagosomal infection","volume":"82","author":"Singh","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.06.013_b0115","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/eji.201141902","article-title":"Perforin plays an unexpected role in regulating T-cell contraction during prolonged Listeria monocytogenes infection","volume":"42","author":"Schmidt","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2017.06.013_b0120","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1073\/pnas.1118868109","article-title":"Division-linked generation of death-intermediates regulates the numerical stability of memory CD8 T cells","volume":"109","author":"Nolz","year":"2012","journal-title":"Proceed Nat Acad Sci"},{"key":"10.1016\/j.vaccine.2017.06.013_b0125","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.4049\/jimmunol.176.5.3028","article-title":"Precursor frequency, nonlinear proliferation, and functional maturation of virus-specific CD4+ T Cells","volume":"176","author":"Whitmire","year":"2006","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17307909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17307909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:23:07Z","timestamp":1759400587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17307909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":25,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0264410X17307909"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.06.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD11a and CD49d enhance the detection of antigen-specific T cells following human vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}